135 related articles for article (PubMed ID: 33865947)
1. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park WH
Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
[TBL] [Abstract][Full Text] [Related]
2. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
3. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
Park WH
Oncol Rep; 2018 Feb; 39(2):860-870. PubMed ID: 29207156
[TBL] [Abstract][Full Text] [Related]
4. The Anti-Apoptotic Effects of Caspase Inhibitors in Propyl Gallate-Treated Lung Cancer Cells Are Related to Changes in Reactive Oxygen Species and Glutathione Levels.
Park WH
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889456
[TBL] [Abstract][Full Text] [Related]
5. The effects of MAPK inhibitors on antimycin A-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species, and glutathione.
Han YH; Park WH
Mol Cell Biochem; 2010 Jan; 333(1-2):211-9. PubMed ID: 19714450
[TBL] [Abstract][Full Text] [Related]
6. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
Park WH; Kim SH
Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
[TBL] [Abstract][Full Text] [Related]
7. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Park WH
Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
[TBL] [Abstract][Full Text] [Related]
8. Propyl gallate decreases the proliferation of Calu-6 and A549 lung cancer cells via affecting reactive oxygen species and glutathione levels.
Park WH
J Appl Toxicol; 2022 Mar; 42(3):436-449. PubMed ID: 34464457
[TBL] [Abstract][Full Text] [Related]
9. The enhancement of propyl gallate-induced HeLa cell death by MAPK inhibitors is accompanied by increasing ROS levels.
You BR; Park WH
Mol Biol Rep; 2011 Apr; 38(4):2349-58. PubMed ID: 21082265
[TBL] [Abstract][Full Text] [Related]
10. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
Park WH
Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
[TBL] [Abstract][Full Text] [Related]
11. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
You BR; Park WH
J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
[TBL] [Abstract][Full Text] [Related]
12. The attenuation of MG132, a proteasome inhibitor, induced A549 lung cancer cell death by p38 inhibitor in ROS-independent manner.
Han YH; Moon HJ; You BR; Park WH
Oncol Res; 2010; 18(7):315-22. PubMed ID: 20377132
[TBL] [Abstract][Full Text] [Related]
13. The effects of buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on propyl gallate-treated HeLa cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2009 Aug; 24(2):261-8. PubMed ID: 19578799
[TBL] [Abstract][Full Text] [Related]
14. Treatment with p38 inhibitor partially prevents Calu-6 lung cancer cell death by a proteasome inhibitor, MG132.
Han YH; Park WH
Cancer Genet Cytogenet; 2010 Jun; 199(2):81-8. PubMed ID: 20471510
[TBL] [Abstract][Full Text] [Related]
15. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
Park WH
Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
[TBL] [Abstract][Full Text] [Related]
16. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
Han YH; Kim SH; Kim SZ; Park WH
Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activated protein kinase inhibitors differently affect the growth inhibition and death of a proteasome inhibitor, MG132-treated human pulmonary fibroblast cells.
Park WH
Hum Exp Toxicol; 2011 Dec; 30(12):1945-54. PubMed ID: 21421692
[TBL] [Abstract][Full Text] [Related]
18. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
19. Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels.
Cui XY; Park SH; Park WH
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014444
[TBL] [Abstract][Full Text] [Related]
20. The effects of N-acetyl cysteine on the MG132 proteasome inhibitor-treated lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2010 Apr; 25(4):657-62. PubMed ID: 20198316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
